Hypnosis and MEOPA in Regional Painful Syndrome Complex (ProHKM-SDRC)

August 22, 2023 updated by: University Hospital, Toulouse

Combined Therapy of Hypnosis Kinesitherapy and MEOPA in Patients With Regional Painful Syndrome Complex

Relation between hypnosis and MEOPA on algodystrophy.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

62

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Quint Fonsegrives, France, 31130
        • Croix du Sud
      • Toulouse, France, 31059
        • University Hospital of Toulouse

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Regional Painful Syndrome Complex

Exclusion Criteria:

  • deaf people

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Hypnosis Kinesitherapy and MEOPA
combined therapy of Hypnosis Kinesitherapy and MEOPA (HKM)
Other: Hypnosis, kinesitherapy, MEOPA
classical intervention
Other Names:
  • Hypnosis Kinesitherapy and MEOPA (HKM)
Other: usual practice
physiopathology and treatments
Other: Usual practice
Usual practice with treatments and physio

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain intensity measure using visual analogical ladder (EVA)
Time Frame: 3 weeks
pain intensity is determined by patient himself on a visual analogical ladder created by Huskisson
3 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
QDSA ( Saint Antoine Pain Questions)
Time Frame: 3 weeks
description of the type of pain
3 weeks
SF36 (Short Form (36) Health Survey)
Time Frame: 3 weeks
quality of life appreciation
3 weeks
HADs
Time Frame: 3 weeks
Hospital Anxiety and Depression Scale
3 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Toulouse

Investigators

  • Principal Investigator: Martine QUINTARD, University Hospital, Toulouse

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 6, 2017

Primary Completion (Actual)

November 7, 2022

Study Completion (Actual)

December 7, 2022

Study Registration Dates

First Submitted

January 24, 2017

First Submitted That Met QC Criteria

August 21, 2017

First Posted (Actual)

August 24, 2017

Study Record Updates

Last Update Posted (Actual)

August 23, 2023

Last Update Submitted That Met QC Criteria

August 22, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RC31/16/8235

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Algodystrophy of Hand

Clinical Trials on Hypnosis, kinesitherapy, MEOPA

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe